ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
15/04/2026
Voltar para busca
Dado oficial do USPTO
NANOTHERM
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
NANOTHERM
ST13
US500000086297568Classe
1, 5, 10, 42, 44
Pedido
86297568
Registro
5047640
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
16/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 10, 42, 44
Data de depósito
02/06/2014
Data de registro
27/09/2016
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
22/09/2023
Última transação
16/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
705
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
27
Localização do titular
BERLIN, DE
Examinador
DOMBROW, COLLEEN M
Unidade examinadora
L10
Titulares e representantes
Titulares
NANOTHERM THERAPEUTICS GMBH
MAGFORCE NT GMBH
MagForce AG
MagForce AG
Representantes
Shauna M. Wertheim THE MARBURY LAW GROUP, PLLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical productsmagnetic nanoparticles composed of iron oxide for use in industry and research; chemical metallic or magnetic particles and nanometer particles for use in industry and research; biopolymers containing metallic nanoparticles for use in industry and research; synthetic and natural oxides in the form of granules and granulates containing iron oxidein particular magnetite and maghemite; chemical products in the form of magnetic nanoparticlessuperparamagnetic nanoparticles and superparamagnetic iron oxide nanoparticles for use in industry and research; chemical preparations in the form of biocompatible polymer nanoparticlesliposomescoated nanoparticlesdrug-containing nanoparticlesall of the foregoing for use in industry and researchfor use in therapy methodsthermotherapy methodsthermoablation methods and/or hyperthermia methodsbut not including radiotherapy methods
Classe 5
Diagnostic agents for medical purposesdiagnostic preparations for medical purposespharmaceuticalveterinary and medical preparations for the treatment of malignant or benign tumor diseasescardiovascular diseasesarthritisarthrosisarteriosclerosisstenosisrestenosis and/or skin diseases containing magnetic particlesmagnetic nanoparticlessuperparamagnetic nanoparticlesnanoparticles comprising iron oxide; pharmaceutical preparations containing metallic or magnetic particles in the nature of nanoparticles for use as anticarcinogenic agents and/or antineoplastic agentsfor treating malignant or benign tumor diseasescardiovascular diseasesarthritisarthrosisarteriosclerosisstenosisrestenosis and/or skin diseases ; contrasting agents for diagnostic imaging for medical purposes; none of the foregoing to be used with radiotherapy for cancer treatment
Classe 10
Medical devices containing magnetic particlesmagnetic nanoparticlessuperparamagnetic nanoparticlesnanoparticles containing iron oxidemagnetic powdersgranulesgranulates containing iron oxide for use in thermotherapy methodsthermoablation methods and/or hyperthermia methodsnone of the foregoing devices comprising compression equipment systems or apparatus or equipment for radiotherapy
Classe 42
Medical and scientific research in the field of cancer and/or cardiovascular treatment and diagnosis; development and design of medical devices containing magnetic particlesmagnetic nanoparticlessuperparamagnetic nanoparticlesnanoparticles containing iron oxideall for treatment and/or diagnosis of cancer and/or cardiovascular diseases ; providing medical testing and information in the field of cancer and cardiovascular research; none of the foregoing services comprising radiotherapy in cancer treatment
Classe 44
Medical servicescancer and cardiovascular therapycancer and cardiovascular treatmentmedical diagnosis of cancer and cardiovascular diseases in the nature of dispensing of medical diagnostics and pharmaceutical and medical preparations containing magnetic particles; conducting medical device-based therapeutic or diagnostic methodsproviding physical therapy using magnetic nanoparticlessuperparamagnetic nanoparticlesnanoparticles containing iron oxide; medical servicestreatment of malignant or benign tumor diseasescardiovascular diseasesarthritisarthrosisarteriosclerosisstenosisrestenosis and/or skin diseases ; medical servicesthermotherapeutic servicesthermoablation methods and/or hyperthermia methods for cancer and cardiovascular treatment using magnetic nanoparticlessuperparamagnetic nanoparticlesnanoparticles; providing medical testing for diagnostic or treatment purposes in the field of cancer and cardiovascular treatment; none of the foregoing services comprising radiotherapy in cancer treatment
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/04/2026
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
27/09/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
22/09/2023
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
22/09/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
22/09/2023
E815
TEAS SECTION 8 & 15 RECEIVED
22/03/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
27/09/2021
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
30/01/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30/01/2017
ES7R
TEAS SECTION 7 REQUEST RECEIVED
14/10/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
27/09/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/07/2016
PUBO
PUBLISHED FOR OPPOSITION
12/07/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/06/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/06/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
31/05/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/05/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/05/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/05/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/11/2015
GNRT
NON-FINAL ACTION E-MAILED
09/11/2015
CNRT
NON-FINAL ACTION WRITTEN
09/11/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/10/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/10/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/10/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
17/04/2015
GNRT
NON-FINAL ACTION E-MAILED
17/04/2015
CNRT
NON-FINAL ACTION WRITTEN
17/04/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/03/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/03/2015
ALIE
ASSIGNED TO LIE
24/03/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/03/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
15/09/2014
GNRT
NON-FINAL ACTION E-MAILED
15/09/2014
CNRT
NON-FINAL ACTION WRITTEN
15/09/2014
DOCK
ASSIGNED TO EXAMINER
15/09/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
13/06/2014
NWAP
NEW APPLICATION ENTERED
05/06/2014
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NANOTHERM ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.